open access
Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes
, 2, 3, 3
Affiliations- Department of Neurology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- Department of Clinical Microbiology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- Department of Neurology, University Hospital Hradec Králové and Faculty of Medicine, Charles University, Hradec Králové, Czech Republic
open access
Abstract
Abstract
Keywords
anti-Hu, anti-GAD antibodies, primary progressive multiple sclerosis, overlapping syndromes
About this articleTitle
Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes
Journal
Neurologia i Neurochirurgia Polska
Issue
Article type
Letter to the Editors
Pages
187-190
Published online
2021-10-27
Page views
5125
Article views/downloads
901
DOI
Pubmed
Bibliographic record
Neurol Neurochir Pol 2022;56(2):187-190.
Keywords
anti-Hu
anti-GAD antibodies
primary progressive multiple sclerosis
overlapping syndromes
Authors
Pavel Štourač
Jana Bednářová
Zbyšek Pavelek
Martin Vališ
References (16)- Titulaer MJ, Höftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014; 75(3): 411–428.
- Naik S, Kolikonda MK, Lippmann S. Progressive encephalomyelitis with rigidity: stiff person syndrome variant associated with multiple sclerosis. Prim Care Companion CNS Disord. 2019; 21(1).
- Thompson A, Banwell B, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology. 2018; 17(2): 162–173.
- Pellizza F, Nobile-Orazio O, Giometto B. Neuronal Nuclear Antibodies ,Type 1(Hu). In: Shoenfeld Y, Meroni PI, Gershwin ME. ed. Autoantibodies. Elsevier 2014.
- Graus F, Saiz A, Dalmau J. GAD antibodies in neurological disorders - insights and challenges. Nat Rev Neurol. 2020; 16(7): 353–365.
- Hadjivassiliou M, Martindale J, Shanmugarajah P, et al. Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients. J Neurol Neurosurg Psychiatry. 2017; 88(4): 301–309.
- Nanri K, Okuma M, Sato S, et al. Prevalence of autoantibodies and the efficacy of immunotherapy for autoimmune cerebellar ataxia. Intern Med. 2016; 55(5): 449–454.
- Herard K, Khanni J, Hibbert KA, et al. Neurological disorders associated with glutamic acid decarboxylase antibodies. Cureus. 2019.
- Meinck HM, Faber L, Morgenthaler N, et al. Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases. J Neurol Neurosurg Psychiatry. 2001; 71(1): 100–103.
- Dalakas MC, Fujii M, Li M, et al. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology. 2000; 55(10): 1531–1535.
- Honnorat J, Saiz A, Giometto B, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol. 2001; 58(2): 225–230.
- Cianci V, Labate A, et al. Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: case report . Seizure. 2010; 19(7): 446–449.
- Duell F, Evertsson B, Al Nimer F, et al. Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS. Neurol Neuroimmunol Neuroinflamm. 2020; 7(4).
- Hottenrott T, Dersch R, Berger B, et al. The MRZ reaction in primary progressive multiple sclerosis. Fluids Barriers CNS. 2017; 14(1): 2.
- Senties-Madrid H, Vega-Boada F. Paraneoplastic syndromes associated with anti-Hu antibodies. Isr Med Assoc J. 2001; 3(2): 94–103.
- Li J, Lin W. Various clinical features of patients with anti-Hu associated paraneoplastic neurological syndromes: An observational study. Medicine (Baltimore). 2018; 97(18): e0649.
